Tuesday, 12 September 2017

Sage's seizure disorder drug fails late-stage trial

(Reuters) - Sage Therapeutics Inc said on Tuesday its drug to treat a life-threatening seizure disorder failed to meet the main goal of a late-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)